Company intelligence / Profile preview

Femtosense

California, United Statesfemtosense.ai ↗

Ownership: Private
Development stage: Commercial

Overview

Femtosense has developed and commercialized an ultra-efficient embedded AI accelerator chip ("SPU-001") that enables advanced neural network inference at extremely low power for edge devices. Its technology powers real-time speech enhancement and noise suppression features in consumer electronics such as hearing aids and wearables. The Clara AI Speech Enhancement system was recently launched commercially through partnerships with device manufacturers like NewSound. The company’s chips are now being integrated into over-the-counter hearing aids to deliver all-day performance on a single charge.

Industry: Digital Health Medical Devices

Partnerships

ABOV SemiconductorImec.IC-linkNewSound Technology Co., Ltd. (“NewSound”)

Beyond the preview

Go deeper on Femtosense.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Femtosense.

Explore the full profile